Systemic treatment in breast-cancer patients with brain metastasis

Author： Arslan Cagatay   Dizdar Omer   Altundag Kadri  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.7, 2010-05, pp. : 1089-1100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial: Adjuvant Systemic Treatment Strategy for Early Breast Cancer

By  

Medicinal Chemistry, Vol. 12, Iss. 3, 2016-05 ,pp. : 257-260

Bentham Science Publishers

Access to resources Recommend Favorite

Systemic NF-κB activation in blood cells of breast cancer patients

By Adžić Miroslav   Nićiforović Ana   Vučić Vesna   Nešković-Konstantinović Zora   Spasić Snežana D.   Jones David R.   Radojčić Marija B.   Spasić Mihajlo B.  

Redox Report, Vol. 11, Iss. 1, 2006-02 ,pp. : 39-44

Maney Publishing

Access to resources Recommend Favorite

Docetaxel as adjuvant and neoadjuvant treatment for patients with breast cancer

By Heys Steven D   Sarkar Tarun   Hutcheon Andrew W  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2147-2157

Informa Healthcare

Access to resources Recommend Favorite

Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer

By  

Current Cancer Drug Targets, Vol. 17, Iss. 5, 2017-05 ,pp. : 479-485

Bentham Science Publishers

Access to resources Recommend Favorite

TOXAPHENE IS ANTIESTROGENIC IN A HUMAN BREAST-CANCER CELL ASSAY

By Arcaro Kathleen F.   Yang Yi   Vakharia Dilip D.   Gierthy John F.  

Journal of Toxicology and Environmental Health, Vol. 59, Iss. 3, 2000-02 ,pp. : 197-210

Taylor & Francis Ltd

Access to resources Recommend Favorite